Klaus Pantel Selected Research

Epithelial Cell Adhesion Molecule

1/2022	Continuous centrifugal microfluidics (CCM) isolates heterogeneous circulating tumor cells via full automation.
10/2021	A Comprehensive Molecular Analysis of in Vivo Isolated EpCAM-Positive Circulating Tumor Cells in Breast Cancer.
3/2020	Clinical Relevance of Circulating Tumor Cells in Esophageal Cancer Detected by a Combined MACS Enrichment Method.
1/2020	Tumor-Associated Release of Prostatic Cells into the Blood after Transrectal Ultrasound-Guided Biopsy in Patients with Histologically Confirmed Prostate Cancer.
11/2019	Detection of Androgen Receptor Variant 7 (ARV7) mRNA Levels in EpCAM-Enriched CTC Fractions for Monitoring Response to Androgen Targeting Therapies in Prostate Cancer.
5/2019	Biology and clinical relevance of EpCAM.
1/2019	Clonality of circulating tumor cells in breast cancer brain metastasis patients.
1/2019	ALDH1-positive intratumoral stromal cells indicate differentiated epithelial-like phenotype and good prognosis in prostate cancer.
1/2019	EGFR and HER3 expression in circulating tumor cells and tumor tissue from non-small cell lung cancer patients.
1/2018	Target Cell Pre-enrichment and Whole Genome Amplification for Single Cell Downstream Characterization.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Klaus Pantel Research Topics

Disease

239	Neoplasms (Cancer) 12/2022 - 01/2002
101	Breast Neoplasms (Breast Cancer) 05/2022 - 07/2003
98	Circulating Neoplastic Cells 12/2022 - 06/2003
66	Neoplasm Metastasis (Metastasis) 12/2022 - 04/2003
37	Prostatic Neoplasms (Prostate Cancer) 02/2022 - 01/2002
23	Carcinoma (Carcinomatosis) 01/2022 - 01/2003
13	Lung Neoplasms (Lung Cancer) 01/2022 - 03/2009
13	Neoplasm Micrometastasis 03/2020 - 05/2004
12	Colorectal Neoplasms (Colorectal Cancer) 09/2021 - 11/2007
11	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 02/2003
11	Lymphatic Metastasis 12/2020 - 08/2005
9	Esophageal Neoplasms (Esophageal Cancer) 10/2021 - 01/2007
8	Disease Progression 05/2022 - 05/2005
8	Adenocarcinoma 02/2022 - 10/2006
7	Brain Neoplasms (Brain Tumor) 01/2021 - 03/2012
6	Residual Neoplasm 01/2022 - 11/2009
6	Carcinogenesis 01/2021 - 01/2009
5	Colonic Neoplasms (Colon Cancer) 01/2022 - 05/2013
5	Melanoma (Melanoma, Malignant) 01/2022 - 04/2003
3	Ovarian Neoplasms (Ovarian Cancer) 12/2021 - 06/2011
3	Hypoxia (Hypoxemia) 02/2021 - 12/2015
3	Urinary Bladder Neoplasms (Bladder Cancer) 12/2020 - 05/2011
3	Ovarian Epithelial Carcinoma 11/2018 - 01/2016
3	Pancreatic Neoplasms (Pancreatic Cancer) 01/2018 - 09/2007
3	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 07/2008 - 09/2006
2	Microsatellite Instability 01/2022 - 06/2004
2	Chromosome Aberrations (Chromosome Abnormalities) 01/2022 - 01/2019
2	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 10/2021 - 01/2017
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 09/2021 - 05/2017
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 09/2021 - 10/2013

Drug/Important Bio-Agent (IBA)

65	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2010
44	DNA (Deoxyribonucleic Acid)IBA 11/2022 - 11/2003
40	Proteins (Proteins, Gene)FDA Link 01/2022 - 06/2004
32	Cell-Free Nucleic AcidsIBA 11/2022 - 06/2004
27	Biological ProductsIBA 01/2022 - 05/2005
27	MicroRNAs (MicroRNA)IBA 01/2021 - 01/2010
23	Keratins (Keratin)IBA 01/2022 - 01/2002
23	Epithelial Cell Adhesion MoleculeIBA 01/2022 - 07/2003
21	Hormones (Hormone)IBA 02/2022 - 08/2005
18	Circulating Tumor DNAIBA 01/2022 - 06/2004
13	AntigensIBA 01/2022 - 01/2002
12	Messenger RNA (mRNA)IBA 01/2022 - 06/2011
11	Estrogen ReceptorsIBA 05/2022 - 05/2004
11	Indicators and Reagents (Reagents)IBA 12/2020 - 09/2003
10	Monoclonal AntibodiesIBA 01/2021 - 04/2003
9	Pharmaceutical PreparationsIBA 12/2022 - 09/2011
9	AntibodiesIBA 01/2018 - 05/2004
8	Tumor Biomarkers (Tumor Markers)IBA 03/2020 - 06/2004
7	RNA (Ribonucleic Acid)IBA 12/2022 - 01/2010
6	Androgen Receptors (Androgen Receptor)IBA 02/2022 - 11/2012
6	ErbB Receptors (EGF Receptor)IBA 01/2022 - 03/2006
6	Estrogens (Estrogen)FDA Link 01/2018 - 11/2005
6	Phenobarbital (Luminal)FDA Link 02/2016 - 04/2004
5	Immune Checkpoint InhibitorsIBA 01/2022 - 11/2015
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019 - 12/2012
5	VimentinIBA 01/2019 - 11/2005
5	Progesterone Receptors (Progesterone Receptor)IBA 01/2018 - 05/2004
5	Progesterone FDA LinkGeneric 01/2018 - 10/2012
5	Prostate-Specific Antigen (Semenogelase)IBA 11/2012 - 01/2002
4	LigandsIBA 01/2022 - 01/2013
4	Phosphotransferases (Kinase)IBA 09/2021 - 01/2013
4	Trastuzumab (Herceptin)FDA Link 08/2014 - 05/2010
4	Protein Isoforms (Isoforms)IBA 05/2014 - 10/2006
4	Epidermal Growth Factor (EGF)IBA 07/2013 - 10/2010
3	CytokinesIBA 01/2022 - 11/2018
3	AndrogensIBA 01/2022 - 09/2011
3	EnzymesIBA 01/2022 - 03/2012
3	Cysteine (L-Cysteine)FDA Link 01/2022 - 02/2021
3	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2022 - 05/2015
3	Small Interfering RNA (siRNA)IBA 02/2021 - 06/2012
3	Activated-Leukocyte Cell Adhesion Molecule (Neurolin)IBA 01/2020 - 09/2011
3	human ERBB2 proteinIBA 10/2018 - 08/2014
3	taxaneIBA 01/2018 - 06/2011
3	Interleukin-8 (Interleukin 8)IBA 01/2018 - 07/2013
3	IntegrinsIBA 11/2015 - 12/2011
3	Transcription Factors (Transcription Factor)IBA 11/2015 - 08/2013
3	ChemokinesIBA 11/2015 - 12/2005
3	Chemokine ReceptorsIBA 09/2013 - 05/2011
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 12/2012 - 03/2005
3	PicoGreenIBA 06/2011 - 01/2011
3	CaspasesIBA 06/2011 - 01/2011
2	von Willebrand FactorIBA 01/2022 - 01/2021
2	E-SelectinIBA 01/2022 - 01/2013
2	Vascular Endothelial Growth Factor CIBA 01/2022 - 01/2007
2	Cadherins (E-Cadherin)IBA 01/2022 - 04/2017
2	Cysteine-Rich Protein 61IBA 11/2021 - 01/2021

Therapy/Procedure

100	Therapeutics 05/2022 - 07/2003
25	Drug Therapy (Chemotherapy) 05/2022 - 06/2003
11	Adjuvant Chemotherapy 01/2019 - 07/2003
10	Neoadjuvant Therapy 01/2022 - 09/2007
9	Castration 01/2021 - 01/2013
8	Cystectomy 12/2020 - 05/2011
7	Immunotherapy 01/2022 - 01/2002
3	Lymph Node Excision (Lymph Node Dissection) 12/2021 - 09/2006
3	Prostatectomy (Retropubic Prostatectomy) 01/2021 - 10/2008
3	Ligation 12/2020 - 05/2011
3	Radiotherapy 07/2019 - 04/2016
3	Transplantation 12/2018 - 03/2015
3	Biological Therapy 08/2008 - 12/2003
2	Aftercare (After-Treatment) 10/2021 - 01/2018